Updated: Aug 11
– FOR IMMEDIATE RELEASE –
Nader Lotfi | Phone: (832) 975-8840, Email: email@example.com, Sugar Land, Texas
Sugar Land, Texas, 5 April 2022: Houston area biotechnology and stem cell banking company Hope Biosciences marks its six-year anniversary this month, celebrating nearly 200 billion cultured mesenchymal stem cells and the myriad of ways those cells are benefitting clients.
Hope Biosciences occupies a unique position in the regenerative medicine space, noteworthy both for patented cell culture methods and its effectiveness getting cells to patients through robust collaboration with academic and clinical research organizations.
“It has been a truly momentous year,” says Hope Biosciences CEO Donna Chang. “In addition to continuing to see our cells at work in hundreds of real people with real needs in a variety of disease indications, we also celebrated the publication of our first peer-reviewed journal article, demonstrating the safety and efficacy of Hope Bio’s cells in rheumatoid arthritis. When I think about this year, I also smile at Wondercell, a gel product that supports skin through optimal cell protein delivery. This product launch was quite an accomplishment for the team, who worked for nearly two years to overcome COVID-related supply chain issues to bring it to the world.”
Hope Biosciences, founded in 2016 by Donna Chang, banks pure mesenchymal stem cells harvested from adult fat or from a newborn’s placenta. How stem cells are preserved, nourished, and grown influences whether those cells can be effectively used when patients need them. A patented process allows Hope Bio’s cell culturists to generate more than 1,000 doses of fresh, pure, undifferentiated cell therapy treatments for each client, exponentially more than any individual can be projected to use in a lifetime. The volume of cells is important because Hope Bio’s research shows that repeated treatments are needed over time to treat chronic disease or injury. Hope Bio’s technology also creates a five-day cell viability window, unprecedented in stem cell culturing, which means Hope Biosciences can confidently ship stem cells throughout the continental United States.
Even in the thrill of astronomical growth, the company maintains their commitment to caring for every cell, every day, by hand.
“Every day it is a privilege to be here, to be trusted,” says Production Manager Hosu Kim. “I have seen nearly all of these 200 billion cells grow in the five years that I have been part of Hope Bio, cultured by the hands of incredible people the inventor of the technology personally qualifies. I never lose the sense of amazement at both science and people.”
Hope Biosciences is a biopharmaceutical company developing adult stem cell therapeutics for a variety of clinical indications, and the only clinical grade adult stem cell banking facility in the nation that banks both adults and newborns. Stem cells cultured at Hope Biosciences, LLC have been and are put to use in dozens of FDA-authorized studies for numerous disease and injury conditions, including COVID-19 prevention and treatment, “Long Haul” COVID, Parkinson’s Disease, Multiple Sclerosis (MS), Alzheimer’s Disease, traumatic brain injury (TBI), amyotrophic lateral sclerosis (ALS), primary lateral sclerosis (PLS), Cerebral Palsy, spinal cord injury, polyneuropathy, muscular dystrophy, lupus, chronic musculoskeletal pain, severe osteoarthritis, and psoriatic arthritis.
Learn more about Hope Biosciences at www.hope.bio.